These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8401816)

  • 1. Inhibition of the effects of rheumatoid synovial fluid cells on chondrogenesis and cartilage breakdown in vitro: possible therapeutical conclusions. A morphological--biochemical study.
    Mohamed-Ali H; Scholz P; Merker HJ
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(1):45-56. PubMed ID: 8401816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of synovial cells on cartilage in vitro: induction of breakdown and inhibition of synthesis.
    Mohamed-Ali H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(4):227-36. PubMed ID: 1359695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo.
    Neidhart M; Seemayer CA; Hummel KM; Michel BA; Gay RE; Gay S
    Arthritis Rheum; 2003 Jul; 48(7):1873-80. PubMed ID: 12847681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synovial factors and chondrocyte-mediated breakdown of cartilage: inhibition by hydrocortisone.
    Steinberg JJ; Sledge CB
    J Orthop Res; 1983; 1(1):13-21. PubMed ID: 6679571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro.
    Mohamed-Ali H
    Rheumatol Int; 1995; 14(5):191-9. PubMed ID: 7724995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destruction of articular cartilage by alpha 2 macroglobulin elastase complexes: role in rheumatoid arthritis.
    Moore AR; Appelboam A; Kawabata K; Da Silva JA; D'Cruz D; Gowland G; Willoughby DA
    Ann Rheum Dis; 1999 Feb; 58(2):109-13. PubMed ID: 10343526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts.
    Neidhart M; Gay RE; Gay S
    Arthritis Rheum; 2000 Aug; 43(8):1719-28. PubMed ID: 10943861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor.
    van der Laan WH; Pap T; Ronday HK; Grimbergen JM; Huisman LG; TeKoppele JM; Breedveld FC; Gay RE; Gay S; Huizinga TW; Verheijen JH; Quax PH
    Arthritis Rheum; 2000 Aug; 43(8):1710-8. PubMed ID: 10943860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
    J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroprotective and anti-inflammatory effects of S-methylisothiourea, an inducible nitric oxide synthase inhibitor in cartilage and synovial explants model of osteoarthritis.
    Balaganur V; Pathak NN; Lingaraju MC; More AS; Latief N; Kumari RR; Kumar D; Tandan SK
    J Pharm Pharmacol; 2014 Jul; 66(7):1021-31. PubMed ID: 24697299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of rheumatoid synovial fluid and cells on proteoglycans in human cartilage explants. Modulation by piroxicam.
    Wilbrink B; Vernooy J; Den Otter W; Van Roy JL; Huber J; Huber-Bruning O
    Clin Rheumatol; 1992 Mar; 11(1):86-91. PubMed ID: 1582126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G; Serni U; Matucci A; Mannoni A; Pucci M; Anichini E; Del Rosso M
    J Rheumatol; 1994 Dec; 21(12):2322-8. PubMed ID: 7699636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts.
    Serratì S; Margheri F; Chillà A; Neumann E; Müller-Ladner U; Benucci M; Fibbi G; Del Rosso M
    Arthritis Rheum; 2011 Sep; 63(9):2584-94. PubMed ID: 21547898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphological changes in the joint tissues and synovial fluid in rheumatoid arthritis and arthrosis deformans].
    Duliapin VA
    Arkh Patol; 1975; 37(8):39-44. PubMed ID: 1167114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synovial and peritoneal macrophages in organoid culture.
    Mohamed-Ali H; de Souza P; Shakibaei M; Hecker-Kia A; Kolkenbrock H; Merker HJ
    Histol Histopathol; 1995 Apr; 10(2):393-403. PubMed ID: 7599436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
    Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
    Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
    Saxne T; Lecander I; Geborek P
    J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface ultrastructure of rheumatoid articular cartilage.
    Kimura H; Tateishi H; Ziff M
    Arthritis Rheum; 1977 Jun; 20(5):1085-94. PubMed ID: 869956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.